title: Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease.
abstract: Dermatologists are ideally suited to manage the various cutaneous sequelae of graft-versus-host disease (GVHD) outlined in part I of this review. However, the complexity of the patient with GVHD, including comorbidities, potential drug interactions related to polypharmacy, and the lack of evidence-based treatment guidelines, are significant challenges to optimizing patient care. In this section, we will provide an outline for the role of the dermatologist in a multispecialty approach to caring for patients with GVHD.
authors.affiliation: Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. srhymes@mdanderson.org
authors.forename: Sharon R
authors.initials: SR
authors.lastname: Hymes
authors.forename: Amin M
authors.initials: AM
authors.lastname: Alousi
authors.forename: Edward W
authors.initials: EW
authors.lastname: Cowen
mesh_terms: D000208:Acute Disease; D000287:Administration, Topical; D000465:Algorithms; D002908:Chronic Disease; D003131:Combined Modality Therapy; D006086:Graft vs Host Disease / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D012871:Skin Diseases / Q000209:etiology / Q000628:therapy; D014467:Ultraviolet Therapy